The SYNTAX Score II (SSII) risk score was developed from the SYNTAX trial to predict 4-year mortality after left main (LM) or multivessel disease revascularization. SSII combines anatomic lesion data… Click to show full abstract
The SYNTAX Score II (SSII) risk score was developed from the SYNTAX trial to predict 4-year mortality after left main (LM) or multivessel disease revascularization. SSII combines anatomic lesion data and selected clinical characteristics (age, sex, COPD, peripheral artery disease, LVEF, creatinine
               
Click one of the above tabs to view related content.